Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Genpact Sees Q3 GAAP EPS $0.74-$0.75 vs $0.74 Est

Author: Benzinga Newsdesk | August 07, 2025 04:33pm
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS9

(Per share data)



 


 


 
Quarter ending September 30, 2025


 


 
Lower

 
Upper
Diluted EPS

 
$                0.74

 
$                0.75
Estimated stock-based compensation expense

 
0.14

 
0.14
Estimated amortization of acquired intangible assets

 
0.05

 
0.05
Estimated tax impact on stock-based compensation expense

 
(0.03)

 
(0.03)
Estimated tax impact on amortization of acquired intangible assets

 
(0.01)

 
(0.01)
Adjusted diluted EPS

 
$               0.89

 
$               0.90

Posted In: G

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist